| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Prognostic model for esophagogastric variceal rebleeding after endoscopic treatment in liver cirrhosis: A Chinese multicenter study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jun-Yi Zhan, Jie Chen, Jin-Zhong Yu, Fei-Peng Xu, Fei-Fei Xing, De-Xin Wang, Ming-Yan Yang, Feng Xing, Jian Wang and Yong-Ping Mu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81874390, 81573948 |
| Shanghai Natural Science Foundation |
21ZR1464100 |
| Science and Technology Innovation Action Plan of Shanghai Science and Technology Commission |
22S11901700 |
| Shanghai Key Specialty of Traditional Chinese Clinical Medicine |
shslczdzk01201 |
|
| Corresponding Author |
Yong-Ping Mu, MD, PhD, Chief Physician, Cell Biology Laboratory, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, No. 528 Zhangheng Road, Pudong District, Shanghai 201203, China. ypmu8888@126.com |
| Key Words |
Esophagogastric variceal bleeding; Variceal rebleeding; Liver cirrhosis; Prognostic model; Risk stratification; Secondary prophylaxis |
| Core Tip |
Rebleeding is a serious complication in liver cirrhosis patients following esophagogastric variceal bleeding, and there is no widely recognized prognostic model to reliably predict this risk. To address this gap, we developed and externally validated the rebleeding event prediction following endoscopic treatment model, which incorporates readily accessible clinical variables from multiple domains. The rebleeding event prediction following endoscopic treatment model enables effective risk stratification, facilitating improved patient management and the tailoring of follow-up and treatment strategies. |
| Publish Date |
2024-12-18 07:36 |
| Citation |
<p>Zhan JY, Chen J, Yu JZ, Xu FP, Xing FF, Wang DX, Yang MY, Xing F, Wang J, Mu YP. Prognostic model for esophagogastric variceal rebleeding after endoscopic treatment in liver cirrhosis: A Chinese multicenter study. <i>World J Gastroenterol</i> 2025; 31(2): 100234</p> |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i2/100234.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i2.100234 |
